DRW Securities LLC acquired a new stake in Enhabit, Inc. (NYSE:EHAB – Free Report) in the third quarter, Holdings Channel.com reports. The firm acquired 41,321 shares of the company’s stock, valued at approximately $326,000.
Other hedge funds also recently bought and sold shares of the company. Marshall Wace LLP purchased a new stake in Enhabit in the 2nd quarter worth approximately $1,941,000. DekaBank Deutsche Girozentrale raised its position in shares of Enhabit by 52.3% in the second quarter. DekaBank Deutsche Girozentrale now owns 518,412 shares of the company’s stock worth $4,306,000 after buying an additional 178,000 shares in the last quarter. WINTON GROUP Ltd bought a new stake in Enhabit during the second quarter valued at $955,000. GSA Capital Partners LLP grew its position in Enhabit by 78.4% during the third quarter. GSA Capital Partners LLP now owns 142,012 shares of the company’s stock worth $1,122,000 after buying an additional 62,397 shares in the last quarter. Finally, AREX Capital Management LP increased its stake in Enhabit by 2.5% in the 2nd quarter. AREX Capital Management LP now owns 2,472,662 shares of the company’s stock worth $22,056,000 after acquiring an additional 59,353 shares during the last quarter.
Wall Street Analyst Weigh In
Separately, Leerink Partners reiterated a “market perform” rating and set a $8.00 price target (down previously from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating and six have assigned a hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $9.25.
Enhabit Stock Performance
NYSE EHAB opened at $7.62 on Wednesday. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The stock’s 50-day simple moving average is $7.50 and its two-hundred day simple moving average is $8.37. Enhabit, Inc. has a twelve month low of $6.85 and a twelve month high of $11.74. The company has a market capitalization of $383.13 million, a price-to-earnings ratio of -3.29 and a beta of 1.84.
Enhabit (NYSE:EHAB – Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The firm had revenue of $253.60 million for the quarter, compared to analysts’ expectations of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same period in the prior year, the business posted $0.03 earnings per share. Research analysts forecast that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.
Enhabit Profile
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Further Reading
- Five stocks we like better than Enhabit
- Breakout Stocks: What They Are and How to Identify Them
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Where to Find Earnings Call Transcripts
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- P/E Ratio Calculation: How to Assess Stocks
- Why Amazon Shares May Never Trade Below $200 Again
Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB – Free Report).
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.